Eagle Asset Management’s Quest Diagnostics DGX Stock Holding History

Eagle Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.29M	Buy	+14,380	New	+$2.15M	0.01%	451

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Eagle Asset Management's DGX Position: Q3 2024 in Review

Eagle Asset Management opened a new position in Quest Diagnostics (DGX) in Q3 2024: 14,380 shares worth $2.29M. The stake represents 0.01% of the portfolio and ranks #451 among its holdings.

846 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

Eagle Asset Management held 14,380 shares of Quest Diagnostics worth $2.29M as of Q3 2024.
Quest Diagnostics was a new Eagle Asset Management position in Q3 2024.
Quest Diagnostics made up 0.01% of Eagle Asset Management's portfolio in Q3 2024, its #451 holding.
846 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.